Skip to content

Single or Double-layer Uterine Closure Techniques

Single or Double-layer Uterine Closure Techniques Following Cesarean: An Ongoing Debate

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03629028
Enrollment
282
Registered
2018-08-14
Start date
2018-08-18
Completion date
2020-03-10
Last updated
2020-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cesarean Section Complications, Cesarean Section; Dehiscence, Uterine Scar

Keywords

cesarean section, niche, isthmocele, uterine closure

Brief summary

There are different surgical techniques of uterine closure during cesarean. A growing data has suggested that the closure technique has an effect on uterine scar healing. Residual myometrium thickness and uterine scar defect (niche) development seems to be related to the single or double layer closure of uterus. In that study, investigators will search for the effect of single or double layer closure of uterus during cesarean on the uterine scar defect.

Detailed description

Study design and participants This study will be assessed cesarean delivery (CD) patients who will admit to the Obstetrics and Gynecology Clinic of the Başkent University Adana Dr. Turgut Noyan Research and Application Center between July 2018 and September 2019. Specifically, participants will be singleton pregnancy patients between 18-45 years of age who will be in gestational weeks 24-41 and had not previously received any uterine operations such as CS or myomectomy. Patients with multiple pregnancies and/or chronic inflammatory diseases such as systemic lupus erythematosus, rheumatoid arthritis, and insulin-dependent diabetes mellitus will be excluded. All patients who meet the inclusion criteria will be randomized into two treatment groups (i.e., single- or double-layer closures). This study was approved by Başkent University Institutional Review Board and Ethics Committee (Project no= KA18-71, Approval Date= 7/27/2018), and supported by Başkent University Research Fund. Patients who will agree to participate in the study will be informed about the purpose of the study before their operations, and each provided signed written consent. Participants will be also assessed for maternal age, gravidity, parity, body mass index, smoking status, diabetes mellitus, hypertensive diseases of pregnancy, and medical history. Regardless of whether they had contractions before surgery, this study also will be determined patient CD indications, levels of cervical dilatation, and how CD will be established (i.e., elective or emergent). Randomization and masking A table of random numbers is used as a simple randomization method for placing participants into the two treatment groups. The Research Randomizer website (https://www.randomizer.org/) was used to create this table. Before the intervention, the next envelope among a previously prepared, sealed, and the number-ordered stack will be opened by a nurse for each procedure. Surgery technique Six operators will perform CD operations. Access to the abdomen will be achieved via Pfannenstiel incision, while the Kerr incision technique will be applied to the uterus for all patients. Patients in the single-layer group will be received uterus closures with locking, while patients in the double-layer group will be received uterus closures with locking in the first layer, but without locking and using the Lambert style in the second layer. The decidua will be deliberately excluded during all suturations. A synthetic absorbable suture material (Vicryl 1.0, Ethicon, Somerville, NJ, USA) will be used during all uterus closures, with corner stitches that will be applied to all patients. Additional suture usages and numbers will be reported only in cases of bleeding. Both uterine closure and whole operation times will be recorded by the respective operating room technicians. Finally, intravenous prophylactic antibiotics (2 g cefazolin sodium) and uterotonic medications (10 IU oxytocin) will be routinely applied during all CD procedures. Follow-up Postoperative follow-ups will be completed in March 2020. All participants will be called after delivery and will be invited to complete sixth-month evaluations. However, participants who will experience post-CD pregnancies or uterine surgeries will be excluded. All remaining participants will be examined at six to nine months period after CD for niche presence in the scar region, niche measurements, scar shape, distance between niche and the external cervical os and residual myometrium thickness (RMT), and adjacent myometrium thicknesses (AMT). The distance between the niche and external os should be measured parallel to the top of the main niche, from the most distal niche point to external os. These examinations will be conducted by two experienced sonographers who will be blinded to clinical information regarding the closure technique. Procedures will be specifically completed using a 4-10 MHz transducer (E8C-RS micro convex endocavity probe, Voluson S6, GE, Milwaukee, US), ultrasonography, and through the saline infusion sonohysterography (SIS) method. The cervix will be first cleaned with povidone iodine while the patient will be on the gynecological examination table prior to ultrasonography. The SIS process then will be progressed toward the inside of the endometrial cavity by passing from the cervical os with an intrauterine insemination cannula (intrauterine insemination catheter, Wallace Artificial Insemination Catheter, Smiths Medical International Ltd., Ashford, Kent, UK). A sterile saline solution will be applied to sufficiently distend the cavity, while ultrasonography will be conducted via transvaginal probe. At this time, the presence of a hypoechogenic area with a depth of 2mm or deeper in the CD scar region within the endometrial cavity will be accepted as a niche. Niche dimensions will be determined via 3-axis measurements for depth, length, and width. Niche shape, distance to the external cervical os, RMT, and AMT will be evaluated. During these follow-ups, patients will be also asked about their menstruation processes and any experiences of cervical pain, menstruation pain, postmenstrual bleeding (PMB) in the form of spotting, and other abnormal bleeding patterns. Those who will experience bleeding for two days or more in the form of spotting after menstruation will be defined as PMB. Participants who will use intrauterine devices after CD and/or those who could not tolerate speculum application will be examined via transvaginal ultrasonography (TV USG). Outcomes Primary outcomes will be considered niche presence and measurements, while secondary outcomes will be considered RMT, AMT, healing ratio, postmenstrual spotting, and dysmenorrhea. Statistical analyses The sample size was calculated based on a study by Di Spiezio Sardo et al. (2017) titled Risk of Cesarean Scar Defect Following Single- vs Double-Layer Uterine Closure: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Their study revealed niche formation rates for single- and double-layer closure types of 25% and 43%, respectively. Based on tools available at the Power and Sample Size website (http://powerandsamplesize.com/Calculators), the needed sample size was calculated at 141 for each treatment group with 90% power and 0.05 alpha error. All data were statistically analyzed using the IBM SPSS 21.0 software. Categorical measurements will be presented as frequencies and percentages, while continuous measurements will be summarized as means and standard deviations (median and range when needed). Distributions will be checked and the student's t-test was will be used for variables meeting the parametric test assumptions when comparing the continuous measurements based on groups, while the Mann Whitney U test will be used for those that will not meet the parametric test assumptions. Finally, chi-square or Fisher's test statistics will be used to compare categorical variables. Statistical significance is set to 0.05 for all tests.

Interventions

DIAGNOSTIC_TESTResidual myometrium thickness

The myometrium will be closed by single or double layer during cesarean and residual myometrium thickness will be evaluated in 6 to 9 months by saline infusion sonography.

DIAGNOSTIC_TESTNiche Presence

The myometrium will be closed by single or double layer during cesarean and niche presence will be evaluated in 6 to 9 months by saline infusion sonography.

DIAGNOSTIC_TESTAdjacent myometrium thickness

The myometrium will be closed by single or double layer during cesarean and adjacent myometrium thickness will be evaluated in 6 to 9 months by saline infusion sonography.

DIAGNOSTIC_TESTNiche Measurements (depth of niche, width of niche, length of niche)

The myometrium will be closed by single or double layer during cesarean and three dimensional niche measurements will be evaluated in 6 to 9 months by saline infusion sonography.

Sponsors

Safak Baran Yilmaz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

Prospective Randomised Trial

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Primary cesarean, singleton pregnancy,

Exclusion criteria

* Multiple pregnancy, History of any uterine surgery, wound healing diseases (insulin dependent diabetes mellitus, rheumatoid arthritis, systemic lupus erythematous, inflammatory bowel disease)

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Niche Visualized by Saline Infusion Sonography6 to 9 monthsThe presence of niche in incision line visualized by saline infusion sonography
Median Depth of Niche6-9 monthswith saline infusion sonohysterography
Median Length of Niche6-9 monthsby saline infusion sonohysterography
Median Width of Niche in Transverse Plane6-9 monthsmedian width of niche in transverse plane by saline infusion sonohysterograhpy

Secondary

MeasureTime frameDescription
Residual Myometrium Thickness - 6 to 9 Months6 to 9 monthsThe residual myometrium thickness in incision line measured by saline infusion sonography
Adjacent Myometrium Thickness6 to 9 monthsAdjacent myometrium thickness out of incision line measured by saline infusion sonography

Countries

Turkey (Türkiye)

Participant flow

Participants by arm

ArmCount
Single Layer
uterus will be sutured by single layer
109
Double Layer
uterus will be sutured by double layer
116
Total225

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall Studyintolerance to examination20
Overall StudyLost to Follow-up2623
Overall StudyPregnancy42

Baseline characteristics

CharacteristicSingle LayerTotalDouble Layer
≥4 cm cervical dilatation11 Participants25 Participants14 Participants
Age, Continuous29.8 years
STANDARD_DEVIATION 4.1
30.3 years
STANDARD_DEVIATION 4.7
30.8 years
STANDARD_DEVIATION 5.1
birth weight3191.5 g
STANDARD_DEVIATION 570
3227.3 g
STANDARD_DEVIATION 602.8
3261.4 g
STANDARD_DEVIATION 633
Body mass index28.9 kg/m^2
STANDARD_DEVIATION 4.2
29.3 kg/m^2
STANDARD_DEVIATION 4.4
29.8 kg/m^2
STANDARD_DEVIATION 4.6
Contractions before labor29 Participants63 Participants34 Participants
Diabetes mellitus6 Participants15 Participants9 Participants
Duration of labor1 hour1 hour1 hour
Duration of uterine closure3.5 min5.2 min6.15 min
Emergent cesarean section30 Participants65 Participants35 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants0 Participants0 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
109 Participants225 Participants116 Participants
Gestational age at delivery38 weeks
STANDARD_DEVIATION 2
38.1 weeks
STANDARD_DEVIATION 2
38.1 weeks
STANDARD_DEVIATION 2.1
History of infertility22 Participants47 Participants25 Participants
Hypertension in pregnancy10 Participants19 Participants9 Participants
Need for additional suture64 Participants130 Participants66 Participants
Nulliparity103 Participants208 Participants105 Participants
Operation time25 min27 min30 min
Sex: Female, Male
Female
109 Participants225 Participants116 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants
Tobacco use5 Participants9 Participants4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1090 / 116
other
Total, other adverse events
1 / 1090 / 116
serious
Total, serious adverse events
0 / 1090 / 116

Outcome results

Primary

Median Depth of Niche

with saline infusion sonohysterography

Time frame: 6-9 months

ArmMeasureValue (MEDIAN)
Single LayerMedian Depth of Niche1.7 mm
Double LayerMedian Depth of Niche2.4 mm
Primary

Median Length of Niche

by saline infusion sonohysterography

Time frame: 6-9 months

Population: of the 225 partipicants included the study

ArmMeasureValue (MEDIAN)
Single LayerMedian Length of Niche3.5 mm
Double LayerMedian Length of Niche3.8 mm
Primary

Median Width of Niche in Transverse Plane

median width of niche in transverse plane by saline infusion sonohysterograhpy

Time frame: 6-9 months

Population: of the 225 participants included the study

ArmMeasureValue (MEDIAN)
Single LayerMedian Width of Niche in Transverse Plane2.8 mm
Double LayerMedian Width of Niche in Transverse Plane4 mm
Primary

Number of Participants With Niche Visualized by Saline Infusion Sonography

The presence of niche in incision line visualized by saline infusion sonography

Time frame: 6 to 9 months

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Single LayerNumber of Participants With Niche Visualized by Saline Infusion Sonographynumber and percentage of niche by saline infusion40 Participants
Single LayerNumber of Participants With Niche Visualized by Saline Infusion Sonographythe presence of niche by tv ultrasound25 Participants
Double LayerNumber of Participants With Niche Visualized by Saline Infusion Sonographynumber and percentage of niche by saline infusion53 Participants
Double LayerNumber of Participants With Niche Visualized by Saline Infusion Sonographythe presence of niche by tv ultrasound23 Participants
Comparison: The sample size was calculated based on the study of Sardo et al. The website http://powerandsamplesize.com/Calculators was used. As a result of the sample size calculation with 90% power and 0.05 alpha error, it was planned to include 141 patients in each group.p-value: 0.05Chi-squared
Secondary

Adjacent Myometrium Thickness

Adjacent myometrium thickness out of incision line measured by saline infusion sonography

Time frame: 6 to 9 months

ArmMeasureValue (MEDIAN)
Single LayerAdjacent Myometrium Thickness12.1 mm
Double LayerAdjacent Myometrium Thickness12 mm
Secondary

Residual Myometrium Thickness - 6 to 9 Months

The residual myometrium thickness in incision line measured by saline infusion sonography

Time frame: 6 to 9 months

ArmMeasureValue (MEDIAN)
Single LayerResidual Myometrium Thickness - 6 to 9 Months9.6 mm
Double LayerResidual Myometrium Thickness - 6 to 9 Months9.4 mm

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026